ZetaRx Biosciences Overview

  • Founded
  • 2008
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

ZetaRx Biosciences General Information

Description

Operator of biotechnology company. The company engages in the development of therapies for cancer and other diseases using genetically engineered lymphocites.

Contact Information

Formerly Known As
ZetaRx
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 1604 5th Avenue
  • Suite 2060
  • Seattle, WA 98101
  • United States
+1 (206) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ZetaRx Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 01-Oct-2013 00.000 Completed Startup
2. Early Stage VC (Series B) 07-Dec-2012 000 00.000 Completed Startup
1. Early Stage VC 21-Dec-2010 $750K $750K Completed Startup
To view ZetaRx Biosciences’s complete valuation and funding history, request access »

ZetaRx Biosciences Executive Team (1)

Name Title Board Seat Contact Info
Cynthia Shumate Executive Vice President
To view ZetaRx Biosciences’s complete executive team members history, request access »

ZetaRx Biosciences Board Members (1)

Name Representing Role Since
Robert Snukal Self Board Member 000 0000
To view ZetaRx Biosciences’s complete board members history, request access »